KYKOY vs CYTK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KYKOY · KYOWA KIRIN CO LTD UNSP ADR EACH REPR 1 ORD SHS$15.31 ▼ 2.52%
CYTK · Cytokinetics$53.69 ▼ 3.35%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KYKOY -3.5%
- CYTK -13.7%
Head to head
| Metric | KYKOY | CYTK |
|---|---|---|
| Price | $15.31 | $53.69 |
| Change today | ▼ 2.52% | ▼ 3.35% |
| Market cap | $7.49B | $7.48B |
| Return, 3 months | -5.2% | -30.7% |
| Return, year to date | +7.1% | -15.5% |
| Return, 1 year | -3.5% | -10.8% |
| P/E (TTM) | 15.2 | – |
| P/B | 0.5 | -23.3 |
| P/E percentile vs own 5y | – | 72nd |
| Dividend yield | 2.74% | – |
| Revenue growth (YoY, latest qtr) | – | -57.1% |
| Net profit growth (YoY) | – | -47.9% |
| Gross margin | – | 80.5% |
| Operating margin | – | -1,046.1% |
| Net margin | – | -1,321.1% |
| Return on equity | – | – |
| Analyst target vs. price | – | +101.6% |
| Analyst buy share | – | 93% |
| RSI (14) | 50 | 27 |
| 30-day volatility | 121.5% | 48.8% |
| Max drawdown, 1 year | -25.9% | -38.5% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- KYKOY is the largest of the group by market value.
- KYKOY has returned the most over the past year.
- CYTK has been the calmest stock over the last 30 days.